Partial Glossectomy for Treatment of Macroglossia Secondary to Myeloma-Associated Amyloidosis: A Case Report Volume 7 - Issue 4

Chong Kim¹, Jeffrey N James², Rafik Abdelsayed³, Caroline Glessner¹, Kyle B Frazier⁴ and Andrew C Jenzer⁶*

• ¹Dental Student, Dental College of Georgia, Augusta University, Georgia
• ²Program Director and Associate Professor, Department of Oral & Maxillofacial Surgery, Augusta University, Georgia
• ³Professor, Department of Oral Biology and Diagnostic Sciences, Augusta University, Georgia
• ⁴Resident, Department of Oral & Maxillofacial Surgery, Augusta University, Georgia
• ⁵Associate Professor, Department of Oral & Maxillofacial Surgery, Augusta University, Georgia

Received: December 06, 2021;   Published: December 14, 2021

Corresponding author: Andrew C Jenzer, Associate Professor, Department of Oral & Maxillofacial Surgery, Augusta University, Georgia

DOI: 10.32474/SJO.2021.07.000273

Fulltext PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Around 10-15% of patients with multiple myeloma develop amyloidosis due to the extracellular deposition of light-chain amyloid molecules. When this deposition occurs in the tongue, patients may exhibit macroglossia. The sequelae of this macroglossia can include dysphagia and gagging, tooth displacement, and airway compromise. This article presents the case of a 43-year-old African American female who was treated with a partial glossectomy secondary to amyloidosis related multiple myeloma.

Abstract| Introduction| Case Description| Discussion| References|